VAERS reports by lot

Pfizer COVID-19 lot EWO185: VAERS reports

38 VAERS reports list lot EWO185 as a Pfizer COVID-19 vaccine, received between 2021-05-12 and 2023-06-02. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
38
Reports
18%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular3921%
General / Systemic (non-local)3921%
Neurological2815%
Gastrointestinal158%
Musculoskeletal148%
Dermatological (non-injection-site)137%
Respiratory95%
Injection-site / Local reaction84%
Thrombotic / Hematological53%
Reproductive / Menstrual53%
Allergic / Anaphylactic42%
Autoimmune / Immune-mediated32%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California7
Texas4
New Jersey3
Virginia3
Massachusetts3
Rhode Island2
Illinois2
Ohio1
Washington1
Michigan1
Indiana1
Puerto Rico1

Reports by month received

2021-055
2021-064
2021-071
2021-085
2021-098
2021-107
2021-111
2022-022
2022-031
2022-041
2022-091
2023-051
2023-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.